Study Demonstrates Fewer Toxicities and Faster Engraftment with Reduced-Dose Methotrexate for Preventing Graft-Versus-Host Disease
Researchers strive to find optimal approach for reducing toxicities resulting from graft-versus-host-disease prophylaxis treatment.